Skip to main content
SpringerLink
Log in

Influenza Vaccination in the Elderly

Impact on Hospitalisation and Mortality

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Influenza causes substantial morbidity across the age spectrum. However, the elderly are especially vulnerable to the serious complications of influenza that might result in hospitalisation or death, and high rates of influenza-associated excess hospitalisation or death that exceed by several-fold the rates seen among most other age groups have consistently been observed in many countries and across many seasons. Thus, the elderly are included among the high priority groups for routine influenza vaccination by many national health authorities.

Inactivated influenza virus vaccines are widely available across the globe and are safe and effective. Vaccination of elderly persons has been associated with significant reductions in hospitalisations for pneumonia and influenza as well as hospitalisations for other cardiopulmonary disorders and even cerebrovascular disease. Vaccination has also been associated with reductions in influenza-associated and all-cause mortality during influenza seasons. The benefits of vaccination extend not only to community-dwelling elderly but also to elderly who reside in nursing homes. Likewise, vaccination provides benefits to the very old and to elderly persons with underlying co-morbidities as well as to the healthy elderly.

Despite the substantially increased risk for serious complications and impressive benefits from vaccination among the elderly, influenza vaccine utilisation remains below target rates for this group in nearly all countries. The need for improved prevention and control of influenza is recognised as a priority for the global community — both to reduce the morbidity and mortality associated with epidemic influenza and to prepare for the next pandemic. Enhancing vaccine delivery to elderly persons would represent important progress toward that goal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V
Table VI
Table VII

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Couch RB. Advances in influenza virus vaccine research. Ann N Y Acad Sci 1993; 685: 802–12

    Article  Google Scholar 

  2. World Health Organization. Influenza vaccines. Wkly Epidemiol Rec 2000; 75: 281–8

    Google Scholar 

  3. Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health 1977; 67: 1063–70

    Article  PubMed  CAS  Google Scholar 

  4. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2004; 53(RR-6): 1–40

    Google Scholar 

  5. Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998; 158: 645–50

    Article  PubMed  CAS  Google Scholar 

  6. World Health Organization. Influenza vaccines. Wkly Epidemiol Rec 2002; 77: 229–40

    Google Scholar 

  7. Van Essen GA, Palache AM, Forleo E, et al. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780–5

    Article  PubMed  Google Scholar 

  8. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333–40

    Article  PubMed  CAS  Google Scholar 

  9. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993; 153: 2105–11

    Article  PubMed  CAS  Google Scholar 

  10. Baltussen RMPM, Reinders A, Sprenger MJW, et al. Estimating influenza-related hospitalization in The Netherlands. Epidemiol Infect 1998; 121: 129–38

    Article  PubMed  CAS  Google Scholar 

  11. Upshur REG, Goel V. Measuring the impact of influenza on the hospitalization rates of the elderly in Ontario: a five-year admission rate analysis, 1988–1993. Can J Public Health 2000; 91: 144–7

    PubMed  CAS  Google Scholar 

  12. Simonsen L, Fukuda K, Schonberger LB, et al. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181(3): 831–7

    Article  PubMed  CAS  Google Scholar 

  13. Nguyen-Van-Tam JS, Brockway CR, Pearson JCG, et al. Excess hospital admissions for pneumonia and influenza in persons ≥65 years associated with influenza epidemics in three English health districts: 1987–95. Epidemiol Infect 2001; 126: 71–9

    Article  PubMed  CAS  Google Scholar 

  14. Scuffham PA. Estimating influenza-related hospital admissions in older people from GP consultation data. Vaccine 2004; 22: 2853–62

    Article  PubMed  Google Scholar 

  15. McBean AM, Hebert PL. New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly. Int J Infect Dis 2004; 8: 227–35

    Article  PubMed  Google Scholar 

  16. Menec VH, Black C, MacWilliam L, et al. The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. Can J Public Health 2003; 94(1): 59–63

    PubMed  Google Scholar 

  17. Menec VH, MacWilliam L, Aoki FY. Hospitalizations and deaths due to respiratory illnesses during influenza seasons: a comparison of community residents, senior housing residents, and nursing home residents. J Gerontol 2002; 57A(10): M629–35

    Google Scholar 

  18. Ellis SE, Coffey CS, Mitchel Jr EF, et al. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003; 51: 761–7

    Article  PubMed  Google Scholar 

  19. Fleming D, Harcourt S, Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989–2001. Commun Dis Public Health 2003; 6: 231–7

    PubMed  CAS  Google Scholar 

  20. Yap FHY, Ho P, Lam K, et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004; 73: 617–23

    Article  PubMed  Google Scholar 

  21. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179–86

    Article  PubMed  Google Scholar 

  22. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178: 53–60

    Article  PubMed  CAS  Google Scholar 

  23. Carrat F, Valleron A. Influenza mortality among the elderly in France, 1980–1990: how many deaths may have been avoided through vaccination? J Epidemiol Community Health 1995; 49: 419–25

    Article  PubMed  CAS  Google Scholar 

  24. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232–9

    Article  PubMed  CAS  Google Scholar 

  25. Neuzil KM, Meilen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225–31

    Article  PubMed  CAS  Google Scholar 

  26. Chiu SS, Lau YL, Chan KH, et al. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 2002; 347: 2097–103

    Article  PubMed  Google Scholar 

  27. Hak E, Wei F, Nordin J, et al. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004; 189: 450–8

    Article  PubMed  Google Scholar 

  28. Margolis KL, Nichol KL, Poland GA, et al. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA 1990; 264: 1139–41

    Article  PubMed  CAS  Google Scholar 

  29. Govaert TME, Aretz K, Masurel N, et al. Adverse reactions to influenza vaccine in elderly people: a randomised double blind placebo controlled trial. BMJ 1993; 307: 988–90

    Article  PubMed  CAS  Google Scholar 

  30. Allsup SJ, Gosney M, Regan M, et al. Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology 2001; 47: 311–4

    Article  PubMed  CAS  Google Scholar 

  31. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998; 351: 326–31

    Article  PubMed  CAS  Google Scholar 

  32. American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345: 1529–36

    Article  Google Scholar 

  33. Tata LJ, West J, Harrison T, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003; 58: 835–9

    Article  PubMed  CAS  Google Scholar 

  34. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 1998; 339: 1797–802

    Article  PubMed  CAS  Google Scholar 

  35. Immunization Safety Review Committee. Institute of Medicine. Immunization safety review. Influenza vaccines and neurological complications. Washington, DC: The National Academies Press, 2004

    Google Scholar 

  36. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004–2005 season. Can Commun Dis Rep 2004; 30(ACS-3): 1–32

    Google Scholar 

  37. Provinciali M, Di Stefano G, Muzzioli M, et al. Impaired antibody response to influenza vaccine in institutionalized elderly. Ann N Y Acad Sci 1994; 717: 307–14

    Article  PubMed  CAS  Google Scholar 

  38. McElhaney JE, Upshaw CM, Hooton JW, et al. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 1998; 16: 1742–7

    Article  PubMed  CAS  Google Scholar 

  39. Deng Y, Jing Y, Campbell AE, et al. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172: 3437–46

    PubMed  CAS  Google Scholar 

  40. Gross PA, Quinnan GV, Weksler ME, et al. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989; 7: 303–8

    Article  PubMed  CAS  Google Scholar 

  41. Muszkat M, Friedman G, Dannenberg HD, et al. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp Gerontol 2003; 38: 1199–203

    Article  PubMed  Google Scholar 

  42. Fulop Jr T, Wagner JR, Khalil A, et al. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol 1999; 54A: M59–64

    Google Scholar 

  43. Beyer WEO, Palache AM, Baljet M, et al. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989; 7: 385–4

    Article  PubMed  CAS  Google Scholar 

  44. Carson PJ, Nichol KL, O’Brien J, et al. Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med 2000; 160: 2017–24

    Article  PubMed  CAS  Google Scholar 

  45. Gross PA, Weksler ME, Quinnan GV, et al. Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol 1987; 25: 1763–5

    PubMed  CAS  Google Scholar 

  46. Gross PA, Quinnan Jr GV, Weksler ME, et al. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc 1988; 36: 209–12

    PubMed  CAS  Google Scholar 

  47. Govaert TME, Thijs CTMCN, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661–5

    Article  PubMed  CAS  Google Scholar 

  48. Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125: 2011–20

    Article  PubMed  Google Scholar 

  49. Nicholson KG, Kent J, Hammersley V. Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993–94; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiol Infect 1999; 123: 103–8

    Article  PubMed  CAS  Google Scholar 

  50. Voordouw BCG, van der Linder PD, Simonian S, et al. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med 2003; 163: 1089–94

    Article  PubMed  Google Scholar 

  51. Allsup S, Haycox A, Regan M, et al. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine 2004; 23: 639–45

    PubMed  Google Scholar 

  52. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–84

    Article  PubMed  CAS  Google Scholar 

  53. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769–76

    Article  PubMed  CAS  Google Scholar 

  54. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001; 184: 665–70

    Article  PubMed  CAS  Google Scholar 

  55. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322–32

    Article  PubMed  Google Scholar 

  56. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947–52

    PubMed  CAS  Google Scholar 

  57. Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1965–1

    Article  Google Scholar 

  58. Foster DA, Talsma A, Furomoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 296–306

    PubMed  CAS  Google Scholar 

  59. Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995; 24: 1240–8

    Article  PubMed  CAS  Google Scholar 

  60. Stamboulian D, Bonvehi PE, Nacinovich FM, et al. Immunization against influenza in the elderly: the Argentinian experience, 1993–1997. Vaccine 1999 Jul 30; 17Suppl. 1: S53–6

    Article  PubMed  Google Scholar 

  61. Crocetti E, Arniani S, Bordoni F, et al. Effectiveness of influenza vaccination in the elderly in a community in Italy. Eur J Epidemiol 2001; 17: 163–8

    Article  PubMed  CAS  Google Scholar 

  62. Puig-Barbera J, Marquez-Calderon S, Masoliver-Fores A, et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997; 51: 526–30

    Article  PubMed  CAS  Google Scholar 

  63. Davis JW, Lee E, Taira DA, et al. Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Med Care 2001; 39: 1273–80

    Article  PubMed  CAS  Google Scholar 

  64. Ahmed AH, Nicholson KG, Nguyen-Van-Tam JS, et al. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemic. Epidemiol Infect 1997; 118: 27–33

    Article  PubMed  CAS  Google Scholar 

  65. Mangtani P, Cumberland P, Hodgson CR, et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004; 190: 1–10

    Article  PubMed  Google Scholar 

  66. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513–8

    Article  PubMed  Google Scholar 

  67. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152: 674–7

    Article  PubMed  CAS  Google Scholar 

  68. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039–45

    Article  PubMed  CAS  Google Scholar 

  69. Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study: one-year follow-up. Eur Heart J 2004; 25: 25–31

    Article  PubMed  Google Scholar 

  70. Jackson LA, Yu O, Heckbert SR, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002; 156: 634–40

    Article  PubMed  Google Scholar 

  71. Wang C, Wang S, Chou P. Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine 2002; 20: 2494–9

    Article  PubMed  Google Scholar 

  72. Shapiro Y, Shemer J, Heymann A, et al. Influenza vaccination: reduction in hospitalizations and death rates among members of ‘Maccabi Healthcare Services’ during the 2000–2001 influenza season. Isr Med Assoc J 2003; 5: 706–9

    PubMed  Google Scholar 

  73. Wang CS, Wang ST, Lai CT, et al. Reducing major causespecific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 2004; 39: 1604–10

    Article  PubMed  Google Scholar 

  74. Nichol KL. Complications of influenza and benefits of vaccination. Vaccine 1999; 17Suppl. 1: S47–52

    Article  PubMed  Google Scholar 

  75. Fleming DM, Watson JM, Nicholas S, et al. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database. Epidemiol Infect 1995; 115: 581–9

    Article  PubMed  CAS  Google Scholar 

  76. Landi F, Onder G, Cesari M, et al. Effects of influenza vaccination on mortality among frail, community-living elderly patients: an observational study. Aging Clin Exp Res 2003; 15: 254–8

    PubMed  Google Scholar 

  77. Armstrong BG, Mangtani P, Fletcher A, et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ 2004; 329: 660

    Article  PubMed  Google Scholar 

  78. Voordouw ACG, Sturkenboom MCJM, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004; 292: 2089–95

    Article  PubMed  CAS  Google Scholar 

  79. Ahmed AEH, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989–90 epidemic. Lancet 1995; 346: 591–5

    Article  PubMed  CAS  Google Scholar 

  80. Vu T, Farish S, Jenkins M, et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20: 1831–6

    Article  PubMed  Google Scholar 

  81. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2003; 35: 370–7

    Article  Google Scholar 

  82. Herzog NS, Bratzier DW, Houck PM, et al. Effects of previous influenza vaccination on subsequent readmission and mortality in elderly patients hospitalized with pneumonia. Am J Med 2003; 115: 454–61

    Article  PubMed  Google Scholar 

  83. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130: 397–403

    PubMed  CAS  Google Scholar 

  84. Schade CP, McCombs MA. Influenza immunization and mortality among diabetic Medicare beneficiaries in West Virginia. W V Med J 2000; 96: 444–8

    PubMed  CAS  Google Scholar 

  85. Strassburg MA, Greenland S, Sorvillo FJ, et al. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4: 38–44

    Article  PubMed  CAS  Google Scholar 

  86. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518–27

    PubMed  CAS  Google Scholar 

  87. Ohmit SE, Arden NH, Monto AS. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. J Am Geriatr Soc 1999; 47: 165–71

    PubMed  CAS  Google Scholar 

  88. Deguchi Y, Takasugi Y, Nishimura K. Vaccine effectiveness for influenza in the elderly in welfare nursing homes during an influenza A (H3N2) epidemic. Epidemiol Infect 2000; 125: 393–7

    Article  PubMed  CAS  Google Scholar 

  89. Saito R, Suzuki H, Oshitani H, et al. The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998–1999 and 1999–2000 seasons. Infect Control Hosp Epidemiol 2002; 23: 82–6

    Article  PubMed  Google Scholar 

  90. Monto AS, Hombuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 2001; 154: 155–60

    Article  PubMed  CAS  Google Scholar 

  91. Centers for Disease Control and Prevention. Update: influenza activity: United States, 1997–98 season. MMWR Morb Mortal Wkly Rep 1998; 47: 196–200

    Google Scholar 

  92. Health Canada. Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003–2004. Can Commun Dis Rep 2004; 30: 109–16

    Google Scholar 

  93. Loeb M, McGeer A, McArthur M, et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999; 159: 2058–64

    Article  PubMed  CAS  Google Scholar 

  94. Rudenko LG, Arden NH, Grigorieva E, et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine 2001; 19: 308–18

    Article  Google Scholar 

  95. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161: 749–59

    Article  PubMed  CAS  Google Scholar 

  96. De Jong JC, Beyer WEP, Palache AM, et al. Mismatch between the 1997–1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000; 61: 94–9

    Article  PubMed  Google Scholar 

  97. Centers for Disease Control and Prevention. Preliminary assessment of the effectiveness of the 2003–04 inactivated influenza vaccine: Colorado, December 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 8–11

    Google Scholar 

  98. Centers for Disease Control and Prevention. Assessment of the effectiveness of the 2003–04 influenza vaccine among children and adults: Colorado, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 707–10

    Google Scholar 

  99. Nichol KL. Live attenuated influenza virus vaccines: new options for the prevention of influenza. Vaccine 2001; 19: 4373–7

    Article  PubMed  CAS  Google Scholar 

  100. Targonski PV, Poland GA. Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly? Drugs Aging 2004; 21: 349–59

    Article  PubMed  Google Scholar 

  101. Treanor JJ, Mattison HR, Dumyati G, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992; 117: 625–33

    PubMed  CAS  Google Scholar 

  102. Gorse GJ, O’Connor TZ, Young SL, et al. Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 2003; 21: 2142–53

    Article  CAS  Google Scholar 

  103. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17: S91–3

    Article  PubMed  Google Scholar 

  104. Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur J Respir Dis 2004; 23: 363–8

    Article  CAS  Google Scholar 

  105. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175: 1–6

    Article  PubMed  CAS  Google Scholar 

  106. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355: 93–7

    Article  PubMed  CAS  Google Scholar 

  107. Arden N, Monto AS, Ohmit SE. Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic. Am J Public Health 1995; 85: 399–401

    Article  PubMed  CAS  Google Scholar 

  108. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344: 889–96

    Article  PubMed  CAS  Google Scholar 

  109. Jin Y, Carriere KC, Predy G, et al. The association between influenza immunization coverage rates and hospitalization for community-acquired pneumonia in Alberta. Can J Public Health 2003; 94: 341–5

    PubMed  Google Scholar 

  110. Simonsen L, Reichert TA, Vibound C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165: 265–72

    Article  PubMed  Google Scholar 

  111. Nichol KL. The efficacy, effectiveness, and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21: 1769–75

    Article  PubMed  Google Scholar 

  112. Stohr K. The global agenda on influenza surveillance and control. Vaccine 2003; 21: 1744–8

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Dr Nichol has received research funding from influenza vaccine manufacturers (Aventis, Swiftwater, PA, USA and MedImmune, Gaithersburg, MD, USA).

Author information

Authors and Affiliations

  1. Minneapolis Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota, USA

    Kristin L. Nichol

Authors
  1. Kristin L. Nichol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristin L. Nichol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nichol, K.L. Influenza Vaccination in the Elderly. Drugs Aging 22, 495–515 (2005). https://doi.org/10.2165/00002512-200522060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200522060-00004

Keywords

Search

Navigation